Abstract
Seven patients receiving continuous ambulatory peritoneal dialysis were given 400 mg of oral metronidazole every eight hours for three days. Plasma, dialysate and urine were collected during the final 24 hours and assayed for metronidazole and its two principal oxidative metabolites by a specific, high-performance, liquid-chromatographic method. Concentrations of metronidazole in plasma and dialysate were similar and were greater than the minimum inhibitory concentration for susceptible anaerobes. There was evidence of retention of both oxidative metabolites. This study shows that oral metronidazole in standard dosages achieves bactericidal concentrations in peritoneal fluid and should be effective in the treatment of peritonitis due to anaerobic bacteria.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
